These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18586091)

  • 1. Micro-particle corrugation, adhesion and inhalation aerosol efficiency.
    Adi S; Adi H; Tang P; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2008 Sep; 35(1-2):12-8. PubMed ID: 18586091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scanning white-light interferometry as a novel technique to quantify the surface roughness of micron-sized particles for inhalation.
    Adi S; Adi H; Chan HK; Young PM; Traini D; Yang R; Yu A
    Langmuir; 2008 Oct; 24(19):11307-12. PubMed ID: 18759384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.
    Adi H; Traini D; Chan HK; Young PM
    J Pharm Sci; 2008 Jul; 97(7):2780-8. PubMed ID: 17894369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM; Wood O; Ooi J; Traini D
    Int J Pharm; 2011 Sep; 416(1):129-35. PubMed ID: 21708238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
    Ooi J; Traini D; Hoe S; Wong W; Young PM
    Int J Pharm; 2011 Jul; 413(1-2):1-9. PubMed ID: 21501674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constant size, variable density aerosol particles by ultrasonic spray freeze drying.
    D'Addio SM; Chan JG; Kwok PC; Prud'homme RK; Chan HK
    Int J Pharm; 2012 May; 427(2):185-91. PubMed ID: 22322208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".
    Young PM; Cocconi D; Colombo P; Bettini R; Price R; Steele DF; Tobyn MJ
    J Pharm Pharmacol; 2002 Oct; 54(10):1339-44. PubMed ID: 12396294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
    Tang P; Chan HK; Chiou H; Ogawa K; Jones MD; Adi H; Buckton G; Prud'homme RK; Raper JA
    Int J Pharm; 2009 Feb; 367(1-2):51-7. PubMed ID: 18848874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
    Jones MD; Harris H; Hooton JC; Shur J; King GS; Mathoulin CA; Nichol K; Smith TL; Dawson ML; Ferrie AR; Price R
    Eur J Pharm Biopharm; 2008 Jun; 69(2):496-507. PubMed ID: 18191553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much particle surface corrugation is sufficient to improve aerosol performance of powders?
    Chew NY; Tang P; Chan HK; Raper JA
    Pharm Res; 2005 Jan; 22(1):148-52. PubMed ID: 15771241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Force control and powder dispersibility of spray dried particles for inhalation.
    Weiler C; Egen M; Trunk M; Langguth P
    J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of solid corrugated particles to enhance powder aerosol performance.
    Chew NY; Chan HK
    Pharm Res; 2001 Nov; 18(11):1570-7. PubMed ID: 11758765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.